Spironolactone Tablet
Product Images NDC 50090-0136

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Spironolactone (NDC 50090-0136). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by A-s Medication Solutions, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

Product Images & Figures Index

FDA Label Image

Chemical Structure (Spironolactone 01)

Chemical Structure (Spironolactone 01)
FDA Label Image

Figure 1 (Spironolactone 02)

Figure 1 (Spironolactone 02)
FDA Label Image

Figure 2 (Spironolactone 03)

Figure 2 (Spironolactone 03)
This appears to be a table showing data related to subgroup analysis for patients with diabetes and hypertension. The table includes values for various biomarkers such as serum creatinine and potassium, as well as treatment with a beta-blocker and spironolactone compared to placebo. Without further context, the purpose or significance of this data is not clear.*
FDA Label Image

Label Image (Lbl500900136)

Label Image (Lbl500900136)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.